In early January 2026, Moderna filed for marketing authorization of its investigational seasonal influenza vaccine mRNA-1010 in the US, EU, Canada, and Australia for adults aged 50 and older, ...

In the latest trading session, Moderna (MRNA) closed at $33.86, marking a -5.66% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%. Meanwhile, the Dow ...

The U.S. stock market closed mixed Thursday, with the S&P 500 edging up less than 0.1% to end nearly flat, the Dow Jones ...

Therefore, any company, regardless of size, can boost its innovation quotient with meaningful impact by adopting the right ...

France has lifted restrictions on Bangladesh and decided to consider it a “Green” listed country with regards to Covid-19.

Groups have also requested records about the work of coronavirus researcher Ralph Baric. A court ruled UNC doesn’t have to turn them all over.

New York City’s school system, the largest in the country, will offer no remote learning option in the fall, requiring all of its 1.1 million students to attend classes in person after more than a ...

The 30-stock Dow gained 159 points, or 0.3%, to 49,621., while the broader market index inched up 0.1% to 6,955.

Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform created by Eli Lilly and ...

BofA Securities is out with a screen of the stocks most shorted by hedge funds as a percentage of float. Strategists estimate that 85% of total short interest in stocks is from hedge funds. The S&P ...

The Trump administration’s unprecedented decision to slash the number of recommended vaccines for children opens the door to ...

Simultaneously, a substantial legal threat has emerged. Bayer AG has filed suit against BioNTech, its partner Pfizer, and competitor Moderna. The litigation centers on patents originally developed by ...